Telehealth booms as demand for GLP-1s surges and questions mount about safety, oversight

Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor, Karleigh McClain was admitted to the hospital, she said. | Primary care's poor track record of addressing weight loss and past shortages of name-brand versions of GLP-1s, such as Ozempic, Mounjaro, and Trulicity, have created a “perfect storm” for telehealth companies to flourish.